期刊文献+

氯沙坦对老年心力衰竭患者血清细胞因子的影响

Effect of losartan on serum cytokines in the elderly with cardiac dysfunction
下载PDF
导出
摘要 目的观察老年心力衰竭患者应用血管紧张素Ⅱ受体拮抗剂(ARB)氯沙坦对血循环中炎性细胞因子的影响。方法64例老年心力衰竭患者(心衰组)随机分为常规治疗组(32例)与氯沙坦组(32例),另设正常对照组(20例)。检测治疗前后血清各炎性细胞因子浓度,并测定其左室射血分数(LVEF)。分析LVEF与细胞因子相关性。结果治疗前与对照组比较,心衰组的细胞因子含量明显升高(P<0·05,P<0·01),心衰组间比较也有明显差别(P<0·01)。氯沙坦组治疗后细胞因子显著下降与常规治疗组比较有显著差异(P<0·01),2组治疗后LVEF较治疗前均有改善。而治疗后氯沙坦组LVEF与细胞因子呈负相关。结论老年心衰患者存在着细胞因子的过度激活,ARB治疗可使血细胞因子浓度降低,并与LVEF改善呈负相关,可能为ARB改善心衰患者预后的重要机制之一。 Objective To study the effect of angiotensin receptor blocker (ARB) losartan on serum cytokines in elderly patients with cardiac dysfunction, Methods Sixty-four elderly patients with cardiac dysfunction were randomly divided into 2 groups: losartan group (32 cases) and general treatment group (32 cases). The serum level of cytokines and the left ventricular ejection fraction (LVEF) were observed before and after treatment. The relation between LVEF and cytokines was analyzed. Results The serum levels of cytokines in elderly patients increased more than those in control groups before treatment( P 〈0.05 ,P 〈 0. 01 ). There was significant difference between losartan group and general treatment group. After treatment the cytokines decreased more significantly in losartan group than those in general treatment group( P 〈 0. 01 ). LVEF improved in the elderly patients after treatment. LVEF in losartan group had significant negative correlation with eytokines. Conclusions There is an excess activation of eytokines in elderly patients with cardiac dysfunction. ARB depresses the levels of cytokines which plays an important role in improving prognosis of elderly patients with heart failure.
出处 《实用老年医学》 CAS 2006年第1期14-16,共3页 Practical Geriatrics
基金 上海市科委科技基金资助项目(01ZB14046)
关键词 心力衰竭 充血性 细胞因子类 洛沙坦 老年人 Heart failure, congestive Cytokine Losartan Aged
  • 相关文献

参考文献10

  • 1Givertz MM, Collucci WS. New targets for heart-failure therapy : endothelin, inflammatory, cytokines, oxidative stress [J]. Lancet, 1998 ,352( Suppl 1 ) :S Ⅰ 34.
  • 2Colucci WS.Molecular and cellular mechanisms of myocardial failure[J].Am J Cardiol,1997,80(11A):15L.
  • 3汪晓云,廖昆灵,王亚非,周群,卢薇.细胞间黏附分子-1及细胞因子与心功能不全的关系[J].中华心血管病杂志,2001,29(11):658-659. 被引量:9
  • 4Sterenage H. Inflammatory mechanisms in atherosclerosis Glaxo-Wellcome Medicines Research Centre [J]. Inflam Res,1997,46(7) :237.
  • 5Liu S, Schreur KD. G protein-mediated suppression of L-Type Ca^2+ current by interleukin-1 beta in cultured rat ventricular myocytes [ J ]. Am J Physiol, 1995,268 ( 2 pt 1 ) :C339.
  • 6Finkel MS, Oddis CV, Jacob TD, et al. Negative inotropic effects of cytokines on the heart mediated by nitric oxide[ J ]. Science, 1992,257 ( 5068 ) :387.
  • 7Eichhom EJ, Bristow MR. Medical therapy can improve the biological properties of the chronically failing heart [ J ]. Circulation, 1996,94(9 ) :2285.
  • 8Teagtmeyer H, Dietz GJ. Perspective : from increased energy metabolism to cardiac hypertrophy and failure:mediators and molecular mechanisms [ J ]. Am J Cardiol, 1999,83 (12A) :1H.
  • 9Cohn JN, Tognoni G. A randomized trial of the angiotensin-receptor blocker valsartan in chronic herat failure [ J ]. N Engl J Med, 2001,345(23) :1667.
  • 10Maggioni AP, Anand I, Gottlieb SO, et al. Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors [ J ]. J Am Coll Cardiol,2002,40(8 ) : 1414.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部